Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RGEN | IBRX | KYMR | ||
| Company | Repligen Corp | Immunitybio Inc | Kymera Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 130.82 | 7.66 | 87.81 | ||
| High | 133.33 | 8.35 | 88.80 | ||
| Low | 129.05 | 7.65 | 86.02 | ||
| Latest | 132.38 | 8.23 | 88.33 | ||
| Change | +1.17 | +0.53 | +0.62 | ||
| % Change | +0.89% | +6.88% | +0.71% | ||
| Volume | 220,660 | 10,622,522 | 125,074 | ||
| 20-Day Average Volume | 807,303 | 21,546,502 | 592,047 | ||
| Previous Close | 131.21 | 7.70 | 87.71 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 120.25 | 7.50 | 84.06 | ||
| 20-Day Raw Stochastic | 92.53% | 55.67% | 89.28% | ||
| 20-Day Relative Strength | 56.89 | 54.07 | 57.17 | ||
| Weighted Alpha | -7.27 | +27.93 | +81.18 | ||
| Today's Opinion | 40% Sell | 72% Buy | 96% Buy | ||
| Previous Opinion | 40% Sell | 56% Buy | 88% Buy | ||
| Last Month's Opinion | 72% Sell | 80% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.00% since 04/13/26 | +12.47% since 04/13/26 | -0.21% since 04/13/26 | ||
| Low | 123.83 on 04/14/26 | 7.12 on 04/16/26 | 84.64 on 04/16/26 | ||
| High | 134.23 on 04/17/26 | 8.35 on 04/20/26 | 90.14 on 04/15/26 | ||
| 1-Month | |||||
| %Chg | +16.26% since 03/20/26 | -3.07% since 03/20/26 | +13.39% since 03/20/26 | ||
| Low | 109.66 on 03/27/26 | 6.54 on 03/24/26 | 73.31 on 03/24/26 | ||
| High | 134.23 on 04/17/26 | 9.54 on 03/23/26 | 90.14 on 04/15/26 | ||
| 3-Month | |||||
| %Chg | -18.94% since 01/20/26 | +26.70% since 01/20/26 | +29.64% since 01/20/26 | ||
| Low | 109.66 on 03/27/26 | 5.54 on 01/28/26 | 67.76 on 01/21/26 | ||
| High | 174.87 on 01/22/26 | 12.43 on 02/25/26 | 95.90 on 02/26/26 | ||
| 6-Month | |||||
| %Chg | -14.33% since 10/20/25 | +235.10% since 10/20/25 | +46.02% since 10/20/25 | ||
| Low | 109.66 on 03/27/26 | 1.95 on 12/31/25 | 55.26 on 10/23/25 | ||
| High | 175.77 on 01/06/26 | 12.43 on 02/25/26 | 103.00 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,400,112 | 7,916,455 | 7,160,819 | ||
| Shares Outstanding, K | 56,399 | 1,028,111 | 81,642 | ||
| Annual Sales | 738,260,000 | 113,290,000 | 39,210,000 | ||
| Annual Net Income | 48,890,000 | -351,400,000 | -311,350,000 | ||
| Last Quarter Sales | 197,910,000 | 38,290,000 | 2,870,000 | ||
| Last Quarter Net Income | 13,290,000 | -61,940,000 | -86,980,000 | ||
| 60-Month Beta | 1.19 | 0.13 | 2.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.49 on 02/24/26 | -0.06 on 02/23/26 | -0.97 on 02/26/26 | ||
| Latest Earnings Date | 05/05/26 | 05/11/26 | 05/08/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 74.32 | 0.00 | 0.00 | ||